Literature DB >> 26567783

Differentiation of Diabetic Macular Edema From Pseudophakic Cystoid Macular Edema by Spectral-Domain Optical Coherence Tomography.

Marion R Munk1, Lee M Jampol2, Christian Simader3, Wolfgang Huf4, Tamara J Mittermüller5, Glenn J Jaffe6, Ursula Schmidt-Erfurth5.   

Abstract

PURPOSE: To differentiate diabetic macular edema (DME) from pseudophakic cystoid macular edema (PCME) based solely on spectral-domain optical coherence tomography (SD-OCT).
METHODS: This cross-sectional study included 134 participants: 49 with PCME, 60 with DME, and 25 with diabetic retinopathy (DR) and ME after cataract surgery. First, two unmasked experts classified the 25 DR patients after cataract surgery as either DME, PCME, or mixed-pattern based on SD-OCT and color-fundus photography. Then all 134 patients were divided into two datasets and graded by two masked readers according to a standardized reading-protocol. Accuracy of the masked readers to differentiate the diseases based on SD-OCT parameters was tested. Parallel to the masked readers, a computer-based algorithm was established using support vector machine (SVM) classifiers to automatically differentiate disease entities.
RESULTS: The masked readers assigned 92.5% SD-OCT images to the correct clinical diagnose. The classifier-accuracy trained and tested on dataset 1 was 95.8%. The classifier-accuracy trained on dataset 1 and tested on dataset 2 to differentiate PCME from DME was 90.2%. The classifier-accuracy trained and tested on dataset 2 to differentiate all three diseases was 85.5%. In particular, higher central-retinal thickness/retinal-volume ratio, absence of an epiretinal-membrane, and solely inner nuclear layer (INL)-cysts indicated PCME, whereas higher outer nuclear layer (ONL)/INL ratio, the absence of subretinal fluid, presence of hard exudates, microaneurysms, and ganglion cell layer and/or retinal nerve fiber layer cysts strongly favored DME in this model.
CONCLUSIONS: Based on the evaluation of SD-OCT, PCME can be differentiated from DME by masked reader evaluation, and by automated analysis, even in DR patients with ME after cataract surgery. The automated classifier may help to independently differentiate these two disease entities and is made publicly available.

Entities:  

Mesh:

Year:  2015        PMID: 26567783     DOI: 10.1167/iovs.15-17042

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

1.  Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty.

Authors:  Koji Kitazawa; Kanae Kayukawa; Koichi Wakimasu; Tsutomu Inatomi; Osamu Hieda; Kazuhiko Mori; Chie Sotozono; Shigeru Kinoshita
Journal:  Jpn J Ophthalmol       Date:  2018-09-25       Impact factor: 2.447

2.  Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema.

Authors:  Asena Keleş Şahin; Ahmet Şahap Kükner; Fatih Ulaş; Ümit Doğan
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

3.  Impact of topical nonsteroidal anti-inflammatory drugs in prevention of macular edema following cataract surgery in diabetic patients.

Authors:  Ahmed A Alnagdy; Hossam Y Abouelkheir; Sherief E El-Khouly; Sahar M Tarshouby
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

4.  Incidence of Pseudophakic Cystoid Macular Oedema Post-Cataract Surgery in Illawarra Shoalhaven Local Health District, Australia.

Authors:  Ishith Seth; Gabriella Bulloch; Alvin Tan; Erin Thornell; Smita Agarwal
Journal:  Biomed Hub       Date:  2022-01-18

Review 5.  Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives.

Authors:  Bora Yüksel; Ömer Karti; Tuncay Kusbeci
Journal:  Clin Ophthalmol       Date:  2017-12-11

6.  Role of combined phacoemulsification and intravitreal injection of bevacizumab in prevention of postoperative macular edema in non-proliferative diabetic retinopathy.

Authors:  Alireza Khodabandeh; Shahed Fadaifard; Ali Abdollahi; Reza Karkhaneh; Ramak Roohipoor; Fatemeh Abdi; Hamed Ghasemi; Sam Habibollahi; Mehdi Mazloumi
Journal:  J Curr Ophthalmol       Date:  2018-05-11

7.  Assessment of patient specific information in the wild on fundus photography and optical coherence tomography.

Authors:  Marion R Munk; Thomas Kurmann; Pablo Márquez-Neila; Martin S Zinkernagel; Sebastian Wolf; Raphael Sznitman
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

8.  Diabetic macular edema treatment guidelines in India: All India Ophthalmological Society Diabetic Retinopathy Task Force and Vitreoretinal Society of India consensus statement.

Authors:  Sneha Giridhar; Lalit Verma; Anand Rajendran; Muna Bhende; Mallika Goyal; Kim Ramasamy; R Padmaja; Sundaram Natarajan; Mahesh Shanmugam Palanivelu; Rajiv Raman; Sobha Sivaprasad
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

9.  Combined Intravitreal Dexamethasone Implant and Cataract Surgery in Patients with Diabetic Retinopathy: Effect on Retinal Morphology and Function.

Authors:  Angelo Maria Minnella; Martina Maceroni; Stefano Maria Picardi; Giorgio Placidi; Elisa De Siena; Stanislao Rizzo; Benedetto Falsini
Journal:  Adv Ther       Date:  2020-09-24       Impact factor: 3.845

10.  Comparison of Efficacy between Non-Steroidal Anti-Inflammatory Drugs and Anti-Vascular Endothelial Growth Factor in Preventing Macular Edema after Cataract Surgery in Diabetic Patients.

Authors:  Chia-An Hsu; Sheng-Chu Chi; Yu-Bai Chou
Journal:  J Pers Med       Date:  2022-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.